About Signum Biosciences
Signum Biosciences is a private biotechnology company dedicated to developing small-molecule therapeutics derived from its Signal Transduction Modulation (STM) platform to modulate signal transduction imbalances. Through research on protein networks that control biological systems, Signum is developing therapeutic candidates for inflammatory and neurodegenerative diseases. Signum's STM technology provides many opportunities for the development of novel consumer products and pharmaceutical candidates.
For more information please visit the Signum website: www.signumbiosciences.com
|SOURCE Signum Biosciences, Inc.|
Copyright©2010 PR Newswire.
All rights reserved